TARGETWATCH
BIBiogaia
Biogaia
Latest price
117.30 SEK
22/07/2026
Latest
140.00 SEK
+19.35%
Upside
3 mo
146.67 SEK
+25.04%
Upside
BIOG-B
3 mo+25.04%3 price targets
6 mo+24.47%5 price targets
1 yr+24.47%5 price targets
Max 6 price targets
Danske BankSB1 MarketsDNB Carnegie
HealthcareDrug Manufacturers—Specialty & Generic

About The Company

Biogaia AB is a Swedish biotechnology company that develops and sells probiotic products. Biogaia has been developed from research findings on the lactic acid bacterium Limosilactobacillus reuteri and the substance reuterin, which was carried out by Walter Dobrogosz and Sven Lindgren in the 1980s.
Wikipedia

Latest Target

Target
140.00 SEK
Upside
+19.35%
Latest price117.30 SEK

Three Month Consensus

Consensus
146.67 SEK
Upside
+25.04%
Latest price117.30 SEK

Insider Trades for Biogaia

No insider trades for the selected period.

More Price Targets for Biogaia

Date
Jul 21

Date
Jul 20

Date
May 8

Analyst
Date
Apr 2

Date
Apr 2